Oxytocin, an OXTR agonist marketed under the trade name OXYTOCIN®, is a medication that has been lauded for its clinical efficacy in the field of obstetrics and gynecology. Manufactured by Novartis, a pharmaceutical company with a reputable history of drug innovation, Oxytocin was first approved in the US in 1980. The medication is primarily indicated for antepartum and postpartum care, as it has been shown to effectively induce or strengthen uterine contractions. Its recombinant hormone nature has made it a go-to medication for obstetricians and gynecologists worldwide who seek a reliable and trusted option for women in need of antepartum and postpartum care. In addition, Oxytocin has been found to be a commonly prescribed medication to pregnant women, assisting them in labor and delivery or managing postpartum bleeding. Click on the image below to begin the exploration journey of Oxytocin through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!